Your browser doesn't support javascript.
loading
Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors.
Yiu, Daniel; Aguilar-Duran, Silvia; Edwards, Charlotte; Chauhan, Dharmisha; Furness, Andrew; Turajlic, Samra; Larkin, James; Fearfield, Louise; Heelan, Kara.
Afiliação
  • Yiu D; Solihull Dermatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Aguilar-Duran S; Royal Marsden Hospital, London, UK.
  • Edwards C; Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
  • Chauhan D; Royal Marsden Hospital, London, UK.
  • Furness A; Royal Marsden Hospital, London, UK.
  • Turajlic S; Royal Marsden Hospital, London, UK.
  • Larkin J; Cancer Dynamics Laboratory, Francis Crick Institute, London, UK.
  • Fearfield L; Royal Marsden Hospital, London, UK.
  • Heelan K; Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Br J Dermatol ; 191(3): 465-467, 2024 Aug 14.
Article em En | MEDLINE | ID: mdl-38753744
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Combinação Trimetoprima e Sulfametoxazol / Toxidermias / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Combinação Trimetoprima e Sulfametoxazol / Toxidermias / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2024 Tipo de documento: Article